A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
for Migraine
114 locations incl. Birmingham
Sponsor: Kallyope Inc.
Sex: All·Age: 18 - 75
Code: NCT07645924·Phase 3·Recruiting·Listed Jun 12, 2026
OnSite Clinical Solutions, LLC
Clinical research site in Charlotte, North Carolina · OnSite Clinical Solutions, 11220 Elm Ln, Charlotte, NC 28277 · (800) 785-3150 · Website
Part of Onsite Clinical Solutions
As of July 2026, 16 paid clinical trials are recruiting at OnSite Clinical Solutions, LLC in Charlotte, North Carolina. Active studies at this site cover conditions such as Migraine, Acute Migraine and COPD. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Recruiting clinical trials at OnSite Clinical Solutions, LLC (16)
A Double-blind, Randomized Controlled Trial to Investigate the Efficacy, Safety, and Pharmacokinetics of Pegloticase Administration Via Subcutaneous and Intravenous Routes Both With Methotrexate in Participants With Uncontrolled Gout
for Uncontrolled Gout
55 locations incl. Birmingham
Sponsor: Amgen
Sex: All·Age: 18+
Code: NCT07388498·Phase 3·Recruiting·Listed Feb 2026
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
for Crohn's Disease
94 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184931·Phase 3·Recruiting·Listed Sep 2025
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Ulcerative Colitis
for Ulcerative Colitis
91 locations incl. Peoria
Sponsor: Sanofi
Sex: All·Age: 16 - 80
Code: NCT07184996·Phase 3·Recruiting·Listed Sep 2025
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for Pediatric Migraine
84 locations incl. Scottsdale
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04649242·Phase 3·Recruiting·Listed Dec 2020
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for Acute Treatment of Migraine
64 locations incl. Scottsdale
Sponsor: Pfizer
Sex: All·Age: 6 - 17
Code: NCT04743141·Phase 3·Recruiting·Listed Feb 2021
A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)
for Coronavirus Disease (COVID-19)
61 locations incl. Paradise Valley
Sponsor: Merck Sharp & Dohme LLC
Sex: All·Age: 18+
Code: NCT06667700·Phase 3·Recruiting·Listed Oct 2024
A Study to Evaluate XEN1101 as Adjunctive Therapy in Primary Generalized Tonic-Clonic Seizures
for Primary Generalized Tonic-Clonic Seizures
51 locations incl. Mobile
Sponsor: Xenon Pharmaceuticals Inc.
Sex: All·Age: 12+
Code: NCT05667142·Phase 3·Recruiting·Listed Dec 2022
A Study of Baricitinib (LY3009104) in Children From 6 Years to Less Than 18 Years of Age With Alopecia Areata
for Areata Alopecia
41 locations incl. Birmingham
Sponsor: Eli Lilly and Company
Sex: All·Age: 6 - 17
Code: NCT05723198·Phase 3·Recruiting·Listed Feb 2023
A Study to Learn About the Study Medicine Called Rimegepant in Adolescents With Frequent Migraine
for Migraine
26 locations incl. Phoenix
Sponsor: Pfizer
Sex: All·Age: 12 - 17
Code: NCT06616194·Phase 3·Recruiting·Listed Sep 2024
An Observational Study of Etrasimod in Adult Patients With Moderate to Severe Ulcerative Colitis
for Colitis, Ulcerative
27 locations incl. Mesa
Sponsor: Pfizer
Sex: All·Age: 18 - 64
Code: NCT06398626·Recruiting·Listed May 2024
A Study to Evaluate Solrikitug in Participants With COPD (ZION)
for COPD
85 locations incl. Birmingham
Sponsor: Uniquity One (UNI)
Sex: All·Age: 40 - 75
Code: NCT06496620·Phase 2·Recruiting·Listed Jul 2024
A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset Seizures
for Focal Seizures
24 locations incl. Phoenix
Sponsor: Jazz Pharmaceuticals
Sex: All·Age: 12 - 75
Code: NCT07233239·Phase 1·Recruiting·Listed Nov 2025
A Study of Modified Release RTN-001 In Patients With Uncontrolled Hypertension
for Uncontrolled Hypertension
22 locations incl. Tucson
Sponsor: Retension Pharmaceuticals. Inc.
Sex: All·Age: 18 - 70
Code: NCT07142356·Phase 2·Recruiting·Listed Aug 2025
Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics And Pharmacodynamics of SIF001 in Healthy Subjects and in Epilepsy Patients
for Epilepsy
10 locations incl. Tucson
Sponsor: Suninflam Inc
Sex: All·Age: 18 - 70·Accepts healthy volunteers
Code: NCT07051629·Phase 1·Recruiting·Listed Jul 2025
Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom Burden
for Sjögren´s Disease
2 locations incl. Charlotte
Sponsor: Novartis Pharmaceuticals
Sex: All·Age: 18+
Code: NCT07621809·Phase 3·Recruiting·Listed Jun 2, 2026
More research sites in Charlotte
- Levine Cancer Institute (57 trials)
- Carolinas Medical Center/Levine Cancer Institute (50 trials)
- Atrium Health (30 trials)
- Novant Health Presbyterian Medical Center (27 trials)
- Atrium Health Pineville/LCI-Pineville (17 trials)
- Atrium Health University City/LCI-University (17 trials)
- Atrium Health Carolinas Medical Center (12 trials)
- Levine Cancer Institute-Ballantyne (12 trials)
- Levine Cancer Institute-SouthPark (11 trials)
- Atrium Health Levine Cancer (9 trials)
Explore more
Paid clinical trials in Charlotte, NC · North Carolina clinical trials